Healthcare / BiotechnologyUpdated 2026-05-10 22:07 UTC

HKG/1801 stock hub

HKG/1801 has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

HKG/1801is not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

156.2B

Hong Kong Stock Exchange

Market data

Live price

Current market quote for this ticker.

Current price

HKG/1801

In the news

Latest news · HKG/1801

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/E48.4

P25 11.7P50 18.9P75 41.4

Trailing P/E172.1

P25 10.7P50 17.9P75 38.5

ROE5

P25 -14.7P50 2P75 9.4

ROIC18.1

P25 -10.4P50 1.9P75 10.5

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All HKG/1801 market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

204

Groups with data

Currency

CNY

Showing 204 of 204 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	Cayman Islands
Country code	HK
Employees	7,502
Employees Change	1,843%
Employees Change Percent	32.57
Enterprise value	HKD 139B
Exchange	Hong Kong Stock Exchange
Financial currency	CNY
First seen	2026-05-10
Industry	Biotechnology
Isin	KYG4818G1010
Last refreshed	2026-05-10
Market cap	HKD 156.2B
Price	HKD 90
Price currency	HKD
Rev Per Employee	1,934,516.19x
Sector	Healthcare
Sic	2836
Symbol	hkg/1801
Website	https://www.innoventbio.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	0.58%
EV Earnings	153.55x
EV/EBIT	196.16x
EV/EBITDA	101.26x
EV/FCF	12.84x
EV/Sales	9.58x
FCF yield	6.93%
Forward P/E	48.41x
P/B ratio	7.25x
P/E ratio	172.08x
P/S ratio	10.76x
PE Ratio3 Y	136x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	5.63%
EBITDA Margin	10.05%
FCF margin	74.62%
Gross margin	76.66%
Gross Profit	HKD 11.1B
Gross Profit Growth	12.27%
Gross Profit Growth Q	25.38%
Gross Profit Growth3 Y	23.27%
Gross Profit Growth5 Y	22.92%
Net Income	HKD 905.3M
Net Income Growth Years	4%
Pretax Margin	6.43%
Profit Margin	6.24%
Profit Per Employee	HKD 120,680
Profitable Years	1
ROA	1.56
Roa5y	-5.5
ROCE	2.53
ROE	5.01
Roe5y	-10.76
ROIC	18.05
Roic5y	-37.84

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr1y	72.15%
Cagr3y	30.01%
Cagr5y	2.22%
EPS Growth Years	4
FCF Growth	2,928.12%
FCF Growth Q	669.91%
OCF Growth	677.07%
OCF Growth Q	544.67%
OCF Growth3 Y	162.16%
Revenue Growth	38.42x
Revenue Growth Q	29.6x
Revenue Growth Quarters	6x
Revenue Growth Years	7x
Revenue Growth3 Y	20.48x
Revenue Growth5 Y	21.05x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	HKD 0.44
Assets	HKD 41.6B
Cash	HKD 20.3B
Current Assets	HKD 25.3B
Current Liabilities	HKD 9.7B
Debt	HKD 3.1B
Debt EBITDA	HKD 2.12
Debt Equity	HKD 0.15
Debt FCF	HKD 0.29
Equity	HKD 21.5B
Interest Coverage	9.22
Liabilities	HKD 20B
Long Term Assets	HKD 16.2B
Long Term Liabilities	HKD 10.4B
Net Cash	HKD 17.2B
Net Cash By Market Cap	HKD 10.98
Net Cash Growth	205.1%
Net Debt EBITDA	HKD -11.77
Net Debt Equity	HKD -0.8
Net Debt FCF	HKD -1.58
Tangible Book Value	HKD 19.8B
Tangible Book Value Per Share	HKD 11.43
WACC	5.51

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	2.62
Inventory Turnover	2.87
Net Working Capital	HKD -4.2B
Quick ratio	2.38
Working Capital	HKD 15.2B
Working Capital Turnover	HKD 1.49

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-6.98%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
1Y total return	72.08%
200-day SMA	89.05
3Y total return	119.78%
50-day SMA	85.76
50-day SMA vs 200-day SMA	50under200
5Y total return	11.59%
All Time High	109.1
All Time High Change	-17.51%
All Time High Date	2025-09-04
All Time Low	14
All Time Low Change	542.86%
All Time Low Date	2018-10-31
ATR	3.63
Beta	0.24
Beta1y	0.8
Beta2y	0.46
Ch YTD	18.03
High	91.05
High52	109.1
High52 Date	2025-09-04
High52ch	-17.51%
Low	88.85
Low52	48.25
Low52 Date	2025-05-12
Low52ch	86.53%
Ma50ch	4.95%
Price vs 200-day SMA	1.07%
RSI	54.05
RSI Monthly	63.68
RSI Weekly	54.42
Sharpe ratio	1.19x
Sortino ratio	2.06
Total Return	-6.98%
Tr YTD	18.03
Tr1m	-1.64%
Tr1w	-2.65%
Tr3m	13.21%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	HKD 816.4M
Operating Income Growth	-32.23
Operating margin	5.63

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	1,610,506,405%
Net Borrowing	-58,432,612.4
Shares Insiders	6.65%
Shares Institutions	48.66%
Shares Out	1,735,191,039
Shares Qo Q	5.48%
Shares Yo Y	6.98%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	HKD 10.1B
Average Volume	11,175,460.15x
Bv Per Share	12.42
CAPEX	HKD -300.3M
Ch1m	-1.64
Ch1w	-2.65
Ch1y	72.08
Ch3m	13.21
Ch3y	119.8
Ch5y	11.59
Ch6m	5.63
Change	-1.21%
Change From Open	-0.11
Close	91.1
Days Gap	-1.1
Depreciation Amortization	663,910,646
Dollar Volume	770,468,670
Earnings Date	2026-08-21
EBIT	HKD 816.4M
EBITDA	HKD 1.5B
EPS	HKD 0.52
F Score	6
FCF	HKD 10.8B
FCF EV Yield	7.79x
FCF Per Share	HKD 6.24
Financing CF	5,261,889,873
Fiscal Year End	December
Founded	2,011
Graham Number	12.07179
Graham Upside	-86.59
Income Tax	HKD 28.2M
Investing CF	-7,246,108,442
Is Primary Listing	1
Last Earnings Date	2026-03-26
Last Report Date	2025-12-31
Ma150	86.88
Ma150ch	3.59%
Ma20	88.61
Ma20ch	1.57%
Net CF	9,016,384,790
Next Earnings Date	2026-08-21
Open	90.1
P FCF Ratio	14.42
P OCF Ratio	14.03
Position In Range	52.27
Ppne	6,266,229,192.7
Price Date	2026-05-08
Price EBITDA	HKD 107
Ptbv Ratio	7.87
Relative Volume	0.75x
Revenue	14,512,740,444x
SBC By Revenue	5.08x
Share Based Comp	737,454,900
Tax By Revenue	0.19x
Tax Rate	3.02%
Tr6m	5.63%
Volume	8,560,763
Z Score	3.93

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

Does HKG/1801 pay a dividend?

Capital-return profile for this ticker.

Performance

HKG/1801 stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns HKG/1801?

Insider, institutional, and short-interest positioning.

Institutional ownership

+48.7%

Share of float held by funds and institutions

Insider ownership

+6.7%

Stake held by company insiders. Higher generally signals alignment.

Short interest

n/a

Float sold short by bearish positioning

Y/Y dilution

+7.0%

Negative means the company is buying back shares.

Technical

HKG/1801 momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

54.1

Neutral momentum band

Price vs 200-day MA

+1.1%

50/200-day relationship not available

Beta (5Y)

0.24

Less volatile than the market

Sharpe ratio

1.19

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About HKG/1801

Hub-level FAQ points readers to the deeper analysis pages.

What is the current hkg/1801 stock rating?

hkg/1801 is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full hkg/1801 analysis?

The full report lives at /stocks/hkg/1801/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for hkg/1801?

The latest report frames hkg/1801 around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the hkg/1801 page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.